Skip to content
Lassa
-
West Africa launches innovative roadmap to ensure equitable access to Lassa fever vaccines
The Lassa Fever E2E Access Roadmap establishes a comprehensive, regionally driven approach that connects every critical stage in transitioning a vaccine from development to sustained, widespread use.
-
Oxford/CEPI Lassa vaccine enters clinical trial in Nigeria
Experts project that up to 700 million people could inhabit areas vulnerable to Lassa fever by 2070.